Fidelity Investments
FBLG icon

Fidelity Investments’s FibroBiologics FBLG Stock Holding History

Fidelity Investments’s Portfolio FBLG Stock Details FBLG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-60
Closed -$655 – 5629
2025
Q3 		$655 Sell
60
-105
-64% -$1.26K ﹤0.01% 5067
2025
Q2 		$2.05K Sell
165
-159
-49% -$2.87K ﹤0.01% 4859
2025
Q1 		$5.83K Buy
324
+12
+4% +$343 ﹤0.01% 4659
2024
Q4 		$12.5K Buy
312
+152
+95% +$8.16K ﹤0.01% 4384
2024
Q3 		$9.86K Buy
+160
New +$10.6K ﹤0.01% 4432

Other funds holding FBLG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CFP
Cascade Financial Partners San Diego, California $1.15B AUM 33.6% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
ANTB
AMG National Trust Bank Greenwood Village, Colorado $4.88B AUM 24.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments's FBLG Position: Q4 2025 in Review

Fidelity Investments sold out of FibroBiologics (FBLG) in Q4 2025, closing a stake of 60 shares — an estimated $655 sold.

Fidelity Investments first reported a position in FBLG in Q3 2024 and held it in 5 quarters. The position peaked at $12.5K in Q4 2024. 45 funds tracked by Wall St. Rank hold FBLG as of Q4 2025.

  • Fidelity Investments reported no remaining FibroBiologics position as of Q4 2025 after selling out during the quarter.
  • Fidelity Investments sold 60 FibroBiologics shares in Q4 2025, an estimated $655.
  • Fidelity Investments first reported a position in FibroBiologics in Q3 2024 and held it in 5 quarters.
  • Fidelity Investments's FibroBiologics position peaked at $12.5K in Q4 2024.
  • 45 funds tracked by Wall St. Rank held FibroBiologics as of Q4 2025.

Based on Fidelity Investments's 13F filing for Q4 2025, filed 17 Feb 2026.